No Chance to Survive: <i>Mo</i>-CBP₃-PepII Synthetic Peptide Acts on <i>Cryptococcus neoformans</i> by Multiple Mechanisms of Action

• Main Authors: Tawanny K. B. Aguiar (Author), Felipe P. Mesquita (Author), Nilton A. S. Neto (Author), Francisco Í. R. Gomes (Author), Cleverson D. T. Freitas (Author), Rômulo F. Carneiro (Author), Celso S. Nagano (Author), Luciana M. R. Alencar (Author), Ralph Santos-Oliveira (Author), Jose T. A. Oliveira (Author), Pedro F. N. Souza (Author)
• Format: Book
• Published: MDPI AG, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Multidrug-resistant <i>Cryptococcus neoformans</i> is an encapsulated yeast causing a high mortality rate in immunocompromised patients. Recently, the synthetic peptide <i>Mo</i>-CBP₃-PepII emerged as a potent anticryptococcal molecule with an MIC₅₀ at low concentration. Here, the mechanisms of action of <i>Mo</i>-CBP₃-PepII were deeply analyzed to provide new information about how it led <i>C. neoformans</i> cells to death. Light and fluorescence microscopies, analysis of enzymatic activities, and proteomic analysis were employed to understand the effect of <i>Mo</i>-CBP₃-PepII on <i>C. neoformans</i> cells. Light and fluorescence microscopies revealed <i>Mo</i>-CBP₃-PepII induced the accumulation of anion superoxide and hydrogen peroxide in <i>C. neoformans</i> cells, in addition to a reduction in the activity of superoxide dismutase (SOD), ascorbate peroxidase (APX), and catalase (CAT) in the cells treated with <i>Mo</i>-CBP₃-PepII. In the presence of ascorbic acid (AsA), no reactive oxygen species (ROS) were detected, and <i>Mo</i>-CBP₃-PepII lost the inhibitory activity against <i>C. neoformans</i>. However, <i>Mo</i>-CBP₃-PepII inhibited the activity of lactate dehydrogenase (LDH) ergosterol biosynthesis and induced the decoupling of cytochrome <i>c</i> (Cyt c) from the mitochondrial membrane. Proteomic analysis revealed a reduction in the abundance of proteins related to energetic metabolism, DNA and RNA metabolism, pathogenicity, protein metabolism, cytoskeleton, and cell wall organization and division. Our findings indicated that <i>Mo</i>-CBP₃-PepII might have multiple mechanisms of action against <i>C. neoformans</i> cells, mitigating the development of resistance and thus being a potent molecule to be employed in the production of new drugs against <i>C. neoformans</i> infections.

Item Description

10.3390/antibiotics12020378
2079-6382